Drug intelligence / Profile preview

PP110

Development stage
Phase 3
Lead developer
Peritech Pharma
Modality
Small Molecules
Administration
Rectal, Topical
01

Overview

PP110 is a Peritech Pharma topical fixed-dose anti-hemorrhoidal product formulated as a gel and medicated wipes. It combines pramoxine 1% for local anesthetic and antipruritic activity with phenylephrine 0.25% for alpha-1 adrenergic vasoconstrictor activity, delivered in a volatile film-forming formulation intended to leave a protective film and prolong contact of the active ingredients with anorectal tissue. PP110 was evaluated once daily in a randomized open-label Phase 2/3 study for grade 2-3 bleeding hemorrhoids, in which the gel outperformed Preparation-H Maximum Strength Cream for reductions in bleeding, pain, and itching. ([europepmc.org](https://europepmc.org/articles/PMC4506449))

Brand names
PP110 GelPP-110 GelPP 110 Gel
Other names
pramoxine and phenylephrine gelPP110 GelPP-110 GelPP 110 Gel
02

Targets

ADRA1A (α1A)NaV alpha (Voltage-gated sodium channel alpha subunit family)

Beyond the preview

Go deeper on PP110.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on PP110.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call